Exact Mass: 557.408
Exact Mass Matches: 557.408
Found 124 metabolites which its exact mass value is equals to given mass value 557.408
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vecuronium
Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. [PubChem] D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
Val Lys Arg Arg
Vecuronium
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
13-hydroxy-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12,14-dimethyl-15-nonyl-9-propan-2-yl-1-oxa-4,7,10-triazacyclopentadecane-2,5,8,11-tetrone
13-hydroxy-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12,14-dimethyl-15-nonyl-9-propan-2-yl-1-oxa-4,7,10-triazacyclopentadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000846388]
13-hydroxy-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12,14-dimethyl-15-nonyl-9-propan-2-yl-1-oxa-4,7,10-triazacyclopentadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000846390]
13-hydroxy-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12,14-dimethyl-15-nonyl-9-propan-2-yl-1-oxa-4,7,10-triazacyclopentadecane-2,5,8,11-tetrone [IIN-based: Match]
Lys Arg Arg Val
Lys Arg Val Arg
Lys Val Arg Arg
Arg Lys Arg Val
Arg Lys Val Arg
Arg Arg Lys Val
Arg Arg Val Lys
Arg Val Lys Arg
Arg Val Arg Lys
Val Arg Lys Arg
Val Arg Arg Lys
13-Hydroxy-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12,14-dimethyl-15-nonyl-9-propan-2-yl-1-oxa-4,7,10-triazacyclopentadecane-2,5,8,11-tetrone
acetic acid [(2S,3S,5R,8S,9R,10R,13R,14R,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-1-piperidin-1-iumyl)-2-(1-piperidinyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester
[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]octadeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxytridecanoylamino)heptadeca-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]tetradec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]tetradeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]heptadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]hexadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]dodec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)pentadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]dodeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]dec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)hexadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)tetradeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(2-hydroxydodecanoylamino)octadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]pentadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(pentadecanoylamino)hexadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(octadecanoylamino)trideca-4,8-diene-1-sulfonic acid
(4E,8E)-2-(dodecanoylamino)-3-hydroxynonadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]hexadec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(undecanoylamino)icosa-4,8-diene-1-sulfonic acid
2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxypentadecane-1-sulfonic acid
(4E,8E)-2-(decanoylamino)-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid
(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytetradecane-1-sulfonic acid
3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]undecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]undec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]heptadec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytetradec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]dodecane-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tridecane-1-sulfonic acid
(4E,8E)-2-(heptadecanoylamino)-3-hydroxytetradeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tetradecanoylamino)heptadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadec-4-ene-1-sulfonic acid
2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydecane-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tridecanoylamino)octadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E)-2-(hexadecanoylamino)-3-hydroxypentadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(nonadecanoylamino)dodeca-4,8-diene-1-sulfonic acid
4-(3-Butanoyloxy-2-heptadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Dodecanoyloxy-3-nonanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Heptanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Hexanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Octadecanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Hexadecanoyloxy-3-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Octanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Acetyloxy-2-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Decanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Decanoyloxy-3-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]decanamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]decanamide
2-[[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Vecuronium
A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents. D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists